LongueVue Capital (LVC), a New Orleans-based private equity firm, has acquired Pinnacle Clinical Research, LLC in San Antonio, Texas.
Pinnacle Clinical Research is a multi-location organization specializing in complex therapeutic areas, including hepatology with a focus on non-alcoholic fatty liver disease and nonalcoholic steatohepatitis. Founded in 2016, Pinnacle has expanded to operate clinical trial sites with facilities in San Antonio, Austin and Georgetown, Texas, supported by more than 100 full-time employees.
Founded in 2001, LVC focuses on providing human capital, financial capital and a skill set built on a successful 20-plus-year record of partnering with entrepreneurs and management teams to drive value creation in middle-market companies. LVC has managed more than $850 million of capital spanning four funds coupled with 150 years of combined operating and investing experience.
Terms of the deal were not disclosed.
According to the LevinPro HC database, this was the 25th clinical trials transaction of 2022. This compares to 15 clinical trials deals reported between January 1, 2021, and November 17, 2021.
